Antibiotics are robust medicines that are widely used from centuries together to treat bacterial infections such as UTI, Typhoid, and Cholera etc. The sim-ilarity between viral and bacterial infection has resulted in the misuse of these antibiotics, the result of which is the development of resistant strains. Such indiscriminate drug usage has been increasing in a vulnerable geriatric and pediatric population. The increase in per capita health expenditure has enhanced the global market of these class of drugs, and the scope is likely to shoot up in the coming years, paving the way for young investors to emerg-ing. The Global market for antibiotics is highly competitive and has a large number of significant players dominating the market share. During the forecast period experts in the field have evaluated Beta-lactam and Beta-lactamase segment to dominate in LAMEA (Latin America, Middle East and Africa) hold-ing the majority of the Market share. However, Asia Pacific was found to be the highest region for contributing more revenues. Detailed market analysis for Beta-lactam/ Beta-lactamase was conducted by doing secondary research where the market segments were compared for antibiotics. The paper dis-cusses several issues related to the area of medicines.
|Number of pages||5|
|Journal||International Journal of Research in Pharmaceutical Sciences|
|Publication status||Published - 09-07-2020|
All Science Journal Classification (ASJC) codes
- Pharmacology, Toxicology and Pharmaceutics(all)